| Balance Sheets | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Cash, cash equivalents and restricted cash | - | - | - | 688,368 |
| Cash and cash equivalents | 580,013 | 629,143 | 698,572 | - |
| Short-term marketable debt securities | 0 | 0 | 0 | 310,701 |
| Accounts receivable, net | 115,585 | 130,252 | 115,426 | 88,465 |
| Inventory, net | 90,489 | 84,061 | 77,256 | 72,298 |
| Prepaid expenses and other current assets, net | 42,798 | 39,976 | 35,772 | 66,883 |
| Total current assets | 828,885 | 883,432 | 927,026 | 1,226,715 |
| Restricted cash | 109,502 | 106,337 | 105,281 | - |
| Property and equipment, net | 124,609 | 126,141 | 129,294 | 125,169 |
| Right-of-use assets, net | 163,550 | 169,768 | 140,500 | 144,964 |
| Intangible assets, net | 5,477 | 5,864 | 6,280 | 7,251 |
| Goodwill | 3,290 | 3,290 | 3,290 | 3,290 |
| Other assets, net | 41,473 | 37,167 | 32,555 | 31,338 |
| Total assets | 1,276,786 | 1,331,999 | 1,344,226 | 1,538,727 |
| Accounts payable | 20,142 | 44,802 | 49,770 | 15,473 |
| Accrued compensation | 98,209 | 68,262 | 63,678 | 80,647 |
| Accrued expenses | 71,707 | 71,011 | 76,003 | 71,671 |
| Deferred revenue | 46,861 | 54,355 | 36,302 | 29,554 |
| Total current liabilities | 236,919 | 238,430 | 225,753 | 197,345 |
| Convertible senior notes, net, principal amount of 1,090,660 and 1,150,000 as of september30, 2025 and december31, 2024, respectively | 1,114,594 | 1,115,526 | 1,116,339 | 1,141,901 |
| Long-term operating lease liabilities | 185,387 | 192,348 | 160,378 | 170,131 |
| Other long-term liabilities | 94,359 | 91,170 | 92,545 | 89,446 |
| Total liabilities | 1,631,259 | 1,637,474 | 1,595,015 | 1,598,823 |
| Common stock, par value of 0.00001 per share 350,000,000 shares authorized 125,982,066 and 123,994,006 shares issued as of september30, 2025 and december31, 2024 and 125,005,715 and 123,994,006 shares outstanding as of september30, 2025 and december31, 2024, respectively | 1 | 1 | 1 | 1 |
| Treasury stock, at cost, 976,351 shares as of september30, 2025 | 45,010 | 45,010 | 45,010 | - |
| Additional paid-in capital | 2,560,814 | 2,516,550 | 2,472,272 | 2,410,416 |
| Accumulated other comprehensive loss | -4,260 | -3,723 | -4,658 | -3,284 |
| Accumulated deficit | -2,866,018 | -2,773,293 | -2,673,394 | -2,467,229 |
| Total stockholders deficit | -354,473 | -305,475 | -250,789 | -60,096 |
| Total liabilities and stockholders deficit | 1,276,786 | 1,331,999 | 1,344,226 | 1,538,727 |
Guardant Health, Inc. (GH)
Guardant Health, Inc. (GH)